SMC approve of nivolumab and cabozantinib
Statement from Kidney Cancer Scotland on the news of the SMC’s approval of nivolumab and cabozantinib for late stage kidney cancer patients... Read More
We would like to invite you to be kept up to date with news from the
charity by signing up to our newsletter. Please enter you email address below.
*By submitting your email address you are agreeing to us contacting you with news and appeals from Kidney Cancer
UK & Scotland. We will never share any of your information with any third parties.